Aslan Pharmaceuticals Ltd
Change company Symbol lookup
Select an option...
ASLN Aslan Pharmaceuticals Ltd
HSTRF Hollister Biosciences Inc
T AT&T Inc
SPHD Invesco S&P 500® High Dividend Low Volatility ETF
MSFT Microsoft Corp
PEY Invesco High Yield Equity Dividend Achievers™ ETF
BAC Bank of America Corp
ARI Apollo Commercial Real Estate Finance Inc
ISNPY Intesa Sanpaolo SpA
BRKR Bruker Corp
Go

Health Care : Biotechnology |
Based in Singapore
Company profile

ASLAN Pharmaceuticals Limited (ASLAN) is a clinical-stage immunology and oncology-focused biopharmaceutical company. ASLAN has a clinical portfolio comprised of a first in class monoclonal therapy, ASLAN004, that is being developed in atopic dermatitis and other immunology indications, and a small molecule inhibitor targeting oncology.

This security is an American depositary receipt
ADR Fees
American Depositary Receipt (ADR) Fee

ADR fees charged by custodial banks normally average from 1 to 3 cents per share. Other country fees might apply. To read more, see the Exception Fees tab at Brokerage Fees

Closing Price
$2.17
Day's Change
0.03 (1.40%)
Bid
--
Ask
--
B/A Size
--
Day's High
2.18
Day's Low
2.10
Volume
(Average)
Volume:
247,869

10-day average volume:
268,537
247,869

Display:

Providers:

UpdateCancel
4 providers

No news found.

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.